CLINICAL TRIALS PROFILE FOR KALBITOR
✉ Email this page to a colleague
All Clinical Trials for KALBITOR
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT01059526 ↗ | Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema | Completed | Shire | 2010-02-01 | The objective of this study is to evaluate the formation of antibodies, the occurence of allergic reactions, and the risk of hypercoagulability and hypocoagulability in patients treated with KALBITOR (ecallantide). | |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for KALBITOR
Condition Name
Clinical Trial Locations for KALBITOR
Trials by Country
Clinical Trial Progress for KALBITOR
Clinical Trial Phase
Clinical Trial Sponsors for KALBITOR
Sponsor Name